Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues by Delforge, Michel, Prof, Bladé, Joan, Prof, Dimopoulos, Meletios A, Prof, Facon, Thierry, Prof, Kropff, Martin, MD, Ludwig, Heinz, Prof, Palumbo, Antonio, Prof, Van Damme, Philip, MD, San-Miguel, Jesús F, Prof, Sonneveld, Pieter, Prof

Get full text

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicent... by Dimopoulos, Meletios A, Prof, Moreau, Philippe, Prof, Palumbo, Antonio, Prof, Joshua, Douglas, Prof, Pour, Ludek, Prof, Hájek, Roman, Prof, Facon, Thierry, Prof, Ludwig, Heinz, Prof, Oriol, Albert, Prof, Goldschmidt, Hartmut, Prof, Rosiñol, Laura, Prof, Straub, Jan, Prof, Suvorov, Aleksandr, Prof, Araujo, Carla, Prof, Rimashevskaya, Elena, Prof, Pika, Tomas, Prof, Gaidano, Gianluca, Prof, Weisel, Katja, Prof, Goranova-Marinova, Vesselina, Prof, Schwarer, Anthony, Prof, Minuk, Leonard, Prof, Masszi, Tamás, Prof, Karamanesht, Ievgenii, Prof, Offidani, Massimo, Prof, Hungria, Vania, Prof, Spencer, Andrew, Prof, Orlowski, Robert Z, MD, Gillenwater, Heidi H, MD, Mohamed, Nehal, PhD, Feng, Shibao, PhD, Chng, Wee-Joo, Prof

Get full text

Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3... by Miguel, Jesus San, Prof, Weisel, Katja, MD, Moreau, Philippe, MD, Lacy, Martha, MD, Song, Kevin, MD, Delforge, Michel, MD, Karlin, Lionel, MD, Goldschmidt, Hartmut, MD, Banos, Anne, MD, Oriol, Albert, MD, Alegre, Adrian, MD, Chen, Christine, MD, Cavo, Michele, MD, Garderet, Laurent, MD, Ivanova, Valentina, MD, Martinez-Lopez, Joaquin, MD, Belch, Andrew, MD, Palumbo, Antonio, MD, Schey, Stephen, MD, Sonneveld, Pieter, MD, Yu, Xin, PhD, Sternas, Lars, MD, Jacques, Christian, MD, Zaki, Mohamed, MD, Dimopoulos, Meletios, MD

Get full text